Making Science Group, S.A. (MAKS.MC)
EUR 7.9
(-3.07%)
EUR 7.9
(-3.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.54 Million | 10.93 Million | 7.21 Million | 3.47 Million | -627.04 Thousand |
| Net Income | -3.8 Million | -3.04 Million | -2.54 Million | 2.07 Million | 777.1 Thousand |
| Depreciation & Amortization | 4.79 Million | 7.58 Million | 3.82 Million | 883.58 Thousand | 440.64 Thousand |
| Deferred income taxes | 163.08 Thousand | -40 Thousand | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -3.15 Million | 5.68 Million | 5.76 Million | 493.53 Thousand | -1.94 Million |
| Other non-cash items | 13.33 Million | 697.85 Thousand | 166.77 Thousand | 24.94 Thousand | 98.4 Thousand |
| Investing Cash Flow | -9.79 Million | -11.19 Million | -29.4 Million | -6.27 Million | -1.51 Million |
| Investments in PPE | -5.91 Million | -4.65 Million | -29.4 Million | -6.6 Million | -1.11 Million |
| Acquisitions | -3.87 Million | -6.53 Million | - | 362.24 Thousand | -404.93 Thousand |
| Investment purchases | -5863.00 | -130.36 Thousand | - | -34.94 Thousand | -404.93 Thousand |
| Sales/Maturities of investments | - | - | - | 362.24 Thousand | 3308.00 |
| Other Investing Activities | - | - | - | -362.24 Thousand | 404.93 Thousand |
| Financing Cash Flow | -758.36 Thousand | 2.51 Million | 40.49 Million | 8.16 Million | 4.32 Million |
| Debt repayment | -3.88 Million | -4.29 Million | -26.58 Million | -7 Million | -1.1 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -246.14 Thousand | -1.18 Million | - | - | - |
| Common Stock Issuance | - | 8.89 Million | 10.55 Million | 1.19 Million | 23.6 Thousand |
| Other Financing Activities | -3.44 Million | -800.64 Thousand | 56.52 Million | 13.98 Million | 5.4 Million |
| Accounts receivables | -2.53 Million | -15.61 Million | -13.09 Million | -6.62 Million | -8.7 Million |
| Accounts payables | -624.72 Thousand | 19.55 Million | 13.67 Million | 5.18 Million | 6.9 Million |
| Inventory | -136.1 Thousand | -1.36 Million | -1.89 Million | -24.24 Thousand | 83.66 Thousand |
| Other working capital | 139.82 Thousand | 7.04 Million | 7.08 Million | 1.96 Million | -232.6 Thousand |
| Cash at beginning of period | 31.34 Million | 30.22 Million | 11.91 Million | 6.55 Million | 4.37 Million |
| Cash at end of period | 19.54 Million | 31.34 Million | 30.22 Million | 11.91 Million | 6.55 Million |
| Capital Expenditure | -5.91 Million | -4.65 Million | -29.4 Million | -6.6 Million | -1.11 Million |
| Effect of forex changes on cash | - | -1.13 Million | -300.65 Thousand | 1.00 | 1.00 |
| Net cash flow / Change in cash | -11.8 Million | 1.12 Million | 18.3 Million | 5.36 Million | 2.17 Million |
| Free Cash Flow | -7.45 Million | 6.27 Million | -22.18 Million | -3.12 Million | -1.74 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -3.8 Million | 749.3 Thousand | -4.55 Million | -2275.24 | -3.46 Million | -3.04 Million |
| Depreciation & Amortization | 4.79 Million | 533.16 Thousand | 4.25 Million | 2128.98 | 4.12 Million | 7.58 Million |
| Deferred income taxes | 163.08 Thousand | 163.08 Thousand | - | - | - | -40 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.15 Million | 10.3 Million | -13.45 Million | -6243.01 | 11.06 Million | 5.68 Million |
| Other non-cash items | 13.33 Million | -3.69 Million | 17.03 Million | -366.95 | 6.11 Million | 697.85 Thousand |
| Investing Cash Flow | -9.79 Million | -4.45 Million | -5.33 Million | -2666.83 | -2.9 Million | -11.19 Million |
| Investments in PPE | -5.91 Million | -3.05 Million | -2.85 Million | -314.79 | 3.63 Million | -4.65 Million |
| Acquisitions | -3.87 Million | -1.4 Million | -2.47 Million | -1237.54 | -6.53 Million | -6.53 Million |
| Investment purchases | -5863.00 | -5863.00 | - | - | - | -130.36 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -1114.50 | - | - |
| Financing Cash Flow | -758.36 Thousand | -2.01 Million | 1.25 Million | 628.84 | -4.22 Million | 2.51 Million |
| Debt repayment | -3.88 Million | -1.98 Million | -1.9 Million | - | -980.02 Thousand | -4.29 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -246.14 Thousand | -246.14 Thousand | - | - | -1.18 Million | -1.18 Million |
| Common Stock Issuance | - | - | - | - | -423.99 Thousand | 8.89 Million |
| Other Financing Activities | -3.44 Million | -2.8 Million | -646.95 Thousand | 628.84 | -1.64 Million | -800.64 Thousand |
| Accounts receivables | -2.53 Million | 4.6 Million | -7.14 Million | -3571.12 | -723.74 Thousand | -15.61 Million |
| Accounts payables | -624.72 Thousand | 349.17 Thousand | -973.89 Thousand | - | 5.1 Million | 19.55 Million |
| Inventory | -136.1 Thousand | 22.32 Thousand | -158.42 Thousand | -79.21 | -301.04 Thousand | -1.36 Million |
| Other working capital | 139.82 Thousand | 5.32 Million | -5.18 Million | -2592.67 | 6.98 Million | 7.04 Million |
| Cash at beginning of period | 31.34 Million | 13.54 Million | 31.34 Million | - | 25.94 Million | 30.22 Million |
| Cash at end of period | 19.54 Million | 19.54 Million | 13.54 Million | -8902.88 | 31.34 Million | 31.34 Million |
| Capital Expenditure | -5.91 Million | -3.05 Million | -2.85 Million | -314.79 | 3.63 Million | -4.65 Million |
| Effect of forex changes on cash | - | - | 5.18 Million | -108.66 | - | -1.13 Million |
| Net cash flow / Change in cash | -11.8 Million | 5.99 Million | -17.8 Million | -8902.88 | 5.4 Million | 1.12 Million |
| Free Cash Flow | -7.45 Million | 8.91 Million | -16.37 Million | -7071.01 | 17.29 Million | 6.27 Million |
4210
CTEK
GFIN
IAFNF
TCLAF
APVS